The European Union has secured about 20,000 additional doses of Remdesivir, announced the spokesman for the European Commission on Wednesday, as reported by Reuters.
“The EU is about to sign a new contract with Gilead for additional doses of Remdesivir,” the spokesman added.
Market reaction
This headline doesn’t seem to be having a significant impact on market sentiment. As of writing, the Euro Stoxx 50 Index was down 0.25% on the day and Germany’s DAX 30 was losing 0.2%. Meanwhile, the EUR/USD pair was up 0.2% at 1.1760.
Share
